SCHEMBL5776802

SCHEMBL5776802

N#Cc1c(N)cccc1-c1cccs1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 8/20 0.55
ADORA2A P29274 6/20 0.55
PIM1 P11309 3/20 0.55
MAPT P10636 3/20 0.50
HSD17B10 Q99714 2/20 0.50
POLB P06746 1/20 0.50
ALOX15 P16050 1/20 0.50
KDM4E B2RXH2 8/20 0.47
ALDH1A1 P00352 5/20 0.47
HPGD P15428 3/20 0.47
GLA P06280 2/20 0.47
GAA P10253 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HCRTR1 O43613 1/20 0.47
ADORA2B P29275 4/20 0.46
CASP1 P29466 1/20 0.45
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12679744 0.87 ADORA2A (0.54) ADORA1ADORA2APIM1MAPTHSD17B10
SCHEMBL768849 0.81 ADORA2A (0.49) ADORA1ADORA2APIM1MAPTHSD17B10
SCHEMBL5325996 0.76 ADORA2A (0.55) ADORA1ADORA2APIM1MAPTHSD17B10
SCHEMBL15365507 0.76 TDO2 (0.46) ADORA1ADORA2APIM1MAPTHSD17B10
SCHEMBL1060974 0.75 ADORA3 (0.56) ADORA1ADORA2APIM1MAPTHSD17B10
SCHEMBL30187653 0.73 TDO2 (0.43) ADORA1ADORA2APIM1MAPTHSD17B10
SCHEMBL28746780 0.73 TSHR (0.48) MAPTHSD17B10KDM4EALDH1A1HPGD
SCHEMBL13029774 0.73 ALDH1A1 (0.44) ADORA1ADORA2APIM1MAPTHSD17B10
SCHEMBL1398115 0.72 ALDH1A1 (0.43) ADORA1ADORA2AMAPTHSD17B10POLB
Hydrochloric Acid SCHEMBL28320768 0.72 ADORA3 (0.53) ADORA1ADORA2APIM1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed